RWDC Industries nabs $188.42m in series B funding round

The company will use the funding to meet growing demand for PHA.

Biotech startup RWDC Industries Limited closed its two-stage series B funding round at $188.42m (US$133m), according to an announcement.

The new investment was co-led by venture capital firm Vickers Venture Partners, energy and resources company Flint Hills Resources, CPV/CAP Pensionskasse Coop, and International SA.

RWDC will use the funding to meet growing demand for PHA, recognised as the only commercially viable biodegradable bioplastic. The funds will also be used to expand the company’s production capacity with a new facility in Athens, Georgia, and to conduct research and development efforts.

Other participating investors include existing investors Eversource Retirement Plan Master Trust and WI Harper Group.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia